期刊文献+

灵芝三萜抑制口腔黏膜癌发展过程的实验研究 被引量:1

Experimental study of the inhibition of triterpenoids isolated from ganoderma lucidum on the development of oral squamous cell carcinoma
下载PDF
导出
摘要 目的:探讨灵芝三萜在口腔癌变发生发展过程中的抑制作用和机制。方法:建立金黄地鼠颊囊动态癌变的动物模型60只,分2组:A组(灵芝三萜组),B组(对照组),每组30只。采用免疫组化技术检测VEGF在2组动物模型中的表达变化,并进行统计学处理。结果:6周时A组正常黏膜上皮例数多于B组,上皮异常增生率A组明显低于B组(P<0.01),9周时中、重度上皮异常增生和癌变率A组低于B组(P<0.05),12周时A组癌变率低于B组(P<0.01)。在整个癌变动态观察期内,2组颊囊癌变过程中不同组织学发生情况有显著差异(P<0.01),A组病变严重程度始终低于B组。VEGF表达强度随着正常黏膜至鳞癌的发展逐渐增强。在上皮单纯增生、上皮异常增生、鳞癌中A组与B组相比,差异均有显著性(P<0.05)。结论:灵芝三萜对口腔黏膜癌发展过程中具有抑制作用并显示出明显的血管抑制作用。 Objective :To discuss the inhibition mechanism of Ganoderma triterpenoids on the development and progression of oral cancer. Methods : 60 hamster cheek pouch dynamic cancer animal models were established and divided into two groups. A group was treated with Ganoderma triterpenoids, B group was as control. The expression of VEGF were detected with immunohistochemistry method. The data was analyzed with CS10.34. Results : The pathological results showed that the normal epithelial cases of group A ( Ganoderma triterpenoids group) were more than those of group B( the control group)and the epithelial dysplasia rate was significantly lower than group B( P 〈 0.01 ) on 6th week. On 9th week the rates of moderate and severe epithelial dysplasia and carcinoma were lower in group A than in group B( P 〈0.05). On 12th week the cancer rate was significantly lower in group A than that in group B(P 〈0.01 ). In the whole dynamic carcinogenesis observation period, the occurrence of two groups'histological difference was significant( P 〈0.01 ). The severity in group A was still lower than that in group B and the grade of cancer induced was lower. Immunohistochemical study showed that the expression of VEGF gradually strengthened with the development of squamous cell carcinoma from normal mucosa. There were significant differences on the three grades, the simple hyperplasia, dysplasia and carcinoma information, of group A and B by rank sum test ( P 〈 0.05 ). Conclusion: Ganoderma triterpenoids can inhibit carcinoma of the oral mueosa and showed significant inhibition of angiogenesis. It can be used for oral squamous cell carcinoma treatment.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2008年第6期784-788,共5页 Journal of Practical Stomatology
基金 吉林省科技厅基金项目(编号:20050405-1)
关键词 灵芝三萜 口腔 鳞状细胞癌 血管上皮生长因子 抗肿瘤 Ganoderma triterpenoids Mouth Squamous cell carcinoma Vascular endothelial growth factor Antitumor
  • 相关文献

参考文献8

  • 1Wang G, Zhao J, Liu J,et al. Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo[ J]. Int Immunopharmacol, 2007,7 (6) : 864 - 870. 被引量:1
  • 2Li CH, Chen PY, Chang UM, et al. Ganoderic acid X, a lanostanoid trilerpene, inhibits topoisomerases and induces apoptosis of cancer cells[J]. Life Sci,2005,77(3 ) :252 - 265. 被引量:1
  • 3Xie JT, Wang CZ, Wicks S,et al. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells[J]. Exp Oncol, 2006,28(1):25-29. 被引量:1
  • 4刘宏伟 胡碧琼 曹采方.口腔白斑癌变的追踪观察及多因素相关分析.上海口腔医学,2004,13:18-18. 被引量:1
  • 5胥文春,陈新敏,罗春丽.血管内皮生长因子受体与恶性肿瘤[J].国外医学(临床生物化学与检验学分册),2003,24(3):158-159. 被引量:7
  • 6赵媛,王丽京,韩冰,马宇光,张洁.Slit蛋白在地鼠颊囊癌变过程中的意义及与血管形成的关系[J].实用口腔医学杂志,2006,22(3):361-364. 被引量:4
  • 7Wong YK, Liu CJ, Kwan PC ,et al. Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betel-associated oral squamous cell carcinoma [ J ]. J Oral Maxillofac Surg,2003,61 ( 11 ) :1257 - 1262. 被引量:1
  • 8Shang ZJ, Li ZB, Li JR. VEGF is up-regulaled by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies[J]. Int J Oral Maxillofac Surg, 2006,35 (6) : 533 -538. 被引量:1

二级参考文献24

  • 1Lamy S,Gingras D,Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation[J]. Cancer Res,2002,62(2) :381-385. 被引量:1
  • 2de Vries C, Escobedo JA, Ueno H, et al. The frms-like tyrosine kinase, a receptor for vascular endothelial growth factor[J]. Science, 1992,255 (5047) : 989-991. 被引量:1
  • 3Terman BI,Dougher-Vermazen M,Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor [J]. Biochem Biophys ResCommun, 1992,187(3) : 1579-1586. 被引量:1
  • 4Galland F,Karamysheva A,Pebusque MJ, et al. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor[J]. Oncogene, 1993,8(5) : 1233-1240. 被引量:1
  • 5Sachie H,Yoshiro M,Akiko O, et al. Involvement of Fit-1 tyrosine kinase(vascular endothelial growth factor receptor-1 ) in pathological angiogenesis[J]. Cancer Res, 2001,61 (3) :1207-1213. 被引量:1
  • 6Shinichi K, Nobuyuki O,Mayumi A, et al. Roles of two receptors, Fit-1 and KDR, in the single transduction of VEGF effects in human vascular endothelial cells[J]. Oncogene,2000,19(17) :2138-2146. 被引量:1
  • 7Padro T,Bieker R, Ruiz S, et al. Overexpression of vascular endothelial growth facotr(VEGF) and its cellular receptor KDR(VEGFR-2) in the bone marrow of patients with acute myeloid leukemia[J]. Leukemia, 2002,16 (7) : 1302-1310. 被引量:1
  • 8Alessandra F,Taghi M,Zeev E, et al. High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia[J]. Clin Cancer Res,2001,7(4) :795-799. 被引量:1
  • 9Prevett M, Hube JR, Li Y, et al. Antivascular endothelial growth factor receptor(fetal liver kinase 1) monoclonal antibody inhibitor tumor angiogenesls and growth of several mouse and human tumors[J]. Cancer Res, 1999,59 (20) :5209-5218. 被引量:1
  • 10Zhu Z,Rockwell P,Lu D, et al. Inhibition of vascular endothelial growth factor-induced receptor activation with antiinase insert domain-containing receptor signle-chain antibodies from a phage display library[J]. Cancer Res, 1998,58(15) :3209-3214. 被引量:1

共引文献9

同被引文献49

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部